Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

December 20, 2022

Patent Application Number

17160628

Date Filed

January 28, 2021

Patent Citations

US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors

US Patent 10208024 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

US Patent 10213427 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

US Patent 10214528 Bicyclic heterocycles as FGFR4 inhibitors

US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors

US Patent 10308644 Heterocyclic compounds as immunomodulators

US Patent 10350240 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

US Patent 10357431 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient

...

Patent Citations Received

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

0

US Patent 12024517 Salts of an FGFR inhibitor

0

Patent Primary Examiner

CPC Code

The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool